- Home
- CZWI vs NERV Comparison
CZWI vs NERV Comparison
Compare CZWI & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZWI | NERV |
|---|---|---|
| Founded | 1938 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.3M | 189.1M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CZWI | NERV |
|---|---|---|
| Price | $18.52 | $3.90 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 46.2K | ★ 61.2K |
| Earning Date | 01-28-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $58,987,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.29 | N/A |
| P/E Ratio | $14.44 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.69 | $1.15 |
| 52 Week High | $18.74 | $12.46 |
Technical Indicators
Market Signals| Indicator | CZWI | NERV |
|---|---|---|
| Relative Strength Index (RSI) | 58.76 | 41.98 |
| Support Level | $17.80 | $3.96 |
| Resistance Level | $18.71 | $4.65 |
| Average True Range (ATR) | 0.47 | 0.37 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 70.19 | 11.71 |
Price Performance
Historical ComparisonAbout CZWI Citizens Community Bancorp Inc.
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.